|
TM2D1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.697070E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.010250E-02 |
| Normal-vs-Stage2 |
1.781920E-02 |
| Normal-vs-Stage3 |
1.478570E-03 |
| Normal-vs-Stage4 |
2.06059999999786E-05 |
| Stage1-vs-Stage2 |
4.800800E-01 |
| Stage1-vs-Stage3 |
2.491000E-01 |
| Stage1-vs-Stage4 |
9.596200E-03 |
| Stage2-vs-Stage3 |
9.149200E-01 |
| Stage2-vs-Stage4 |
2.736800E-01 |
| Stage3-vs-Stage4 |
2.043000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.101100E-03 |
| Normal-vs-AfricanAmerican |
2.053700E-02 |
| Normal-vs-Asian |
9.016600E-03 |
| Caucasian-vs-AfricanAmerican |
8.268000E-01 |
| Caucasian-vs-Asian |
8.462400E-01 |
| AfricanAmerican-vs-Asian |
9.474000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.965200E-04 |
| Normal-vs-Female |
4.597300E-03 |
| Male-vs-Female |
2.468400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.391910E-02 |
| Normal-vs-Age(41-60Yrs) |
3.879000E-03 |
| Normal-vs-Age(61-80Yrs) |
5.025700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.062430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.650400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.506600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.023800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.120600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.056400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.429800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.824200E-01 |
| Classical-VS-Follicular |
5.919600E-01 |
| Classical-VS-Other |
1.787960E-01 |
| Classical-VS-Normal |
7.035700E-03 |
| Tall-VS-Follicular |
5.729200E-01 |
| Tall-VS-Other |
4.410800E-01 |
| Tall-VS-Normal |
4.901100E-03 |
| Follicular-VS-Other |
4.062000E-01 |
| Follicular-VS-Normal |
1.318090E-02 |
| Other-VS-Normal |
2.159800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.359400E-03 |
| Normal-vs-N1 |
7.63920000000917E-05 |
| N0-vs-N1 |
5.834500E-02 |
|
|
